RxDoctor Payments Data

Mark Hall

Podiatrist · Lake Worth, FLNPI 1104899764

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.4%), education and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.6%. Reporting peaked in 2024 at $4,883 and has fallen 66.1% since, to $1,657 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,337in general payments, 2019–2025

Across 135 payments — averaging $113.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$4K
  • Southern Edge Orthopaedics, Inc.$4K
  • Stryker$2K
  • Integra Lifesciences Corporation$1K
  • Smith+Nephew$951
  • Treace Medical Concepts, Inc.$888
  • plus $3K from 20 others

What the payments were for

  • Grants$3,50023%
  • Travel & lodging$3142%
  • Food & beverage$7,27647%
  • Education$3,50923%
  • Other$7385%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,337 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$476,964
Medicare patients
839
Services billed
5,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin31$172
Colchicine14$154
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$149
Cephalexin33$138

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lake Worth

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →